SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $697,467,372 |
| Positions | 23 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| AMYLYX PHARMACEUTICALS INC | AMLX | COM | $83,048,854 | 4,624,101 |
| ALUMIS INC | ALMS | COM | $82,040,566 | 2,915,443 |
| ABIVAX SA | ABVX | SPONSORED ADS | $69,143,950 | 518,865 |
| VAXCYTE INC | PCVX | COM | $49,579,891 | 852,914 |
| IMMIX BIOPHARMA INC | IMMX | COM | $48,028,403 | 4,658,429 |
| PHARVARIS N V | PHVS | COM | $45,442,339 | 1,314,122 |
| JAZZ PHARMACEUTICALS PLC | JAZZ | SHS USD | $38,781,230 | 160,938 |
| CELCUITY INC | CELC | COM | $38,742,669 | 370,318 |
| DISC MEDICINE INC | IRON | COM | $38,378,752 | 524,730 |
| CANDEL THERAPEUTICS INC | CADL | COM | $34,027,966 | 3,303,686 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.